Sequenom Announces Formation Of Ophthalmology Clinical Advisory Board

Sequenom, Inc. (Nasdaq: SQNM) today announced the formation of a new clinical advisory board focusing on retinal diseases and conditions. The initial three distinguished thought-leaders will provide guidance to Sequenom and Sequenom Center for Molecular Medicine (Sequenom CMM) regarding the development of retinal care molecular diagnostics.

Full Story →